4//SEC Filing
Komjathy Andrew 4
Accession 0001179110-20-001598
CIK 0001454789other
Filed
Feb 13, 7:00 PM ET
Accepted
Feb 14, 12:57 PM ET
Size
14.6 KB
Accession
0001179110-20-001598
Insider Transaction Report
Form 4
Komjathy Andrew
Chief Commercial Officer
Transactions
- Award
Stock Option (right to buy)
2020-02-12+35,000→ 35,000 totalExercise: $5.32Exp: 2030-02-11→ Common Stock (35,000 underlying)
Footnotes (1)
- [F1]This option was granted on February 12, 2020 and is subject to vesting over a four year period, with 25% of the shares vesting on the first anniversary of February 12, 2020 and the remainder vesting over the ensuing three years at a rate of 2.0833% per month.
Documents
Issuer
CATABASIS PHARMACEUTICALS INC
CIK 0001454789
Entity typeother
Related Parties
1- filerCIK 0001788465
Filing Metadata
- Form type
- 4
- Filed
- Feb 13, 7:00 PM ET
- Accepted
- Feb 14, 12:57 PM ET
- Size
- 14.6 KB